Clinical Trials Browser

Phase 2 × INDUSTRY × dexamethasone acetate × Clear all

NCT06979596 2026-03-06

OMAHA-015

Phase 2 Recruiting

Neoplasms

NCT02294357 2023-11-01

Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib

Phase 2 Terminated

Multiple Myeloma, Recurrence